Therefore, the deficiency of FTO can help to sensitize melanoma cells to IFN-γ stimulation and increase the efficacy of anti-PD-1 immunotherapy in mice bearing melanoma xenograft tumor, which is associated with the activation of adaptive immunity (128). The gene discussed is FTO; the disease is melanoma.